Trials / Conditions / Locally Advanced Lung Carcinoma
Locally Advanced Lung Carcinoma
7 registered clinical trials studyying Locally Advanced Lung Carcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Cadonilimab(AK104) Plus Concurrent Chemoradiotherapy in Patients With Locally Advanced, Unresectable, Stage II NCT06448910 | Fudan University | Phase 2 |
| Recruiting | Esomeprazole and Radiation Induced Esophagitis NCT06120803 | Rush University Medical Center | Phase 2 |
| Unknown | ProCaLung: Project on Cancer of the Lung NCT04726358 | Jules Bordet Institute | — |
| Completed | Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC NCT04951063 | Sun Yat-sen University | Phase 1 |
| Recruiting | Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patien NCT04680377 | Jun Zhang, MD, PhD | — |
| Terminated | Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced L NCT03735095 | Roswell Park Cancer Institute | Phase 1 / Phase 2 |
| Recruiting | Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types NCT06075524 | Mayo Clinic | — |